Ajanta Pharma Ltd

ajantapharma.com BSE: 532331 NSE : AJANTPHARM
About [ edit ]

Ajanta Pharma is primarily engaged in development, manufacturing and marketing of speciality pharmaceutical quality finished dosages.(Source : 202003-01 Annual Report Page No:70)

Key Points [ edit ]
Website BSE NSE
  • Market Cap ₹ 16,497 Cr.
  • Current Price ₹ 1,909
  • High / Low ₹ 2,049 / 1,330
  • Stock P/E 25.2
  • Book Value ₹ 346
  • Dividend Yield 0.68 %
  • ROCE 32.0 %
  • ROE 23.4 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company has been maintaining a healthy dividend payout of 19.14%
  • Company's median sales growth is 18.72% of last 10 years

Cons

  • The company has delivered a poor sales growth of 10.56% over past five years.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021
511 544 485 515 612 643 651 682 668 716 749 757
354 378 378 388 444 465 465 531 445 442 507 497
Operating Profit 157 166 107 127 168 178 186 151 223 274 242 259
OPM % 31% 31% 22% 25% 28% 28% 29% 22% 33% 38% 32% 34%
Other Income 8 15 4 2 8 12 14 54 13 5 5 3
Interest 0 0 0 1 2 5 2 4 2 2 3 3
Depreciation 17 17 19 19 23 23 24 26 28 28 29 31
Profit before tax 148 164 93 109 151 162 175 176 207 249 215 229
Tax % 29% 23% 28% 19% 24% 28% 39% 27% 29% 32% 18% 30%
Net Profit 106 125 67 89 115 116 108 129 148 170 177 159
EPS in Rs 12.02 14.25 7.60 10.19 13.14 13.33 12.33 14.80 16.93 19.51 20.41 18.40
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
409 498 677 931 1,208 1,474 1,749 1,983 2,126 2,055 2,588 2,890
330 409 545 706 840 969 1,161 1,292 1,467 1,489 1,904 1,891
Operating Profit 79 89 132 224 369 504 589 691 658 567 683 999
OPM % 19% 18% 19% 24% 31% 34% 34% 35% 31% 28% 26% 35%
Other Income 1 10 6 6 14 9 20 20 24 21 88 26
Interest 20 18 15 19 9 6 5 1 0 1 12 8
Depreciation 21 25 32 34 44 52 44 61 60 72 96 116
Profit before tax 39 56 91 177 330 456 559 648 623 514 664 900
Tax % 12% 10% 15% 37% 29% 32% 26% 22% 25% 25% 30% 27%
Net Profit 34 51 77 112 234 310 416 507 469 387 468 654
EPS in Rs 3.86 5.76 8.78 12.74 26.61 35.25 47.23 57.59 53.25 44.35 53.60 75.56
Dividend Payout % 12% 12% 11% 13% 15% 17% 17% 23% 0% 20% 24% 13%
Compounded Sales Growth
10 Years:19%
5 Years:11%
3 Years:11%
TTM:12%
Compounded Profit Growth
10 Years:29%
5 Years:9%
3 Years:12%
TTM:39%
Stock Price CAGR
10 Years:49%
5 Years:4%
3 Years:23%
1 Year:37%
Return on Equity
10 Years:27%
5 Years:24%
3 Years:21%
Last Year:23%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Corporate actions
Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
12 12 12 12 18 18 18 18 18 18 18 17
Reserves 173 217 286 382 576 823 1,173 1,550 2,024 2,228 2,581 2,978
Borrowings 228 191 200 125 130 72 81 1 2 36 46 31
82 103 151 200 226 233 207 254 383 383 649 752
Total Liabilities 495 522 649 718 949 1,146 1,479 1,823 2,426 2,664 3,293 3,779
168 214 246 273 279 288 451 589 1,053 1,178 1,472 1,541
CWIP 47 17 3 12 94 170 240 339 61 262 132 108
Investments 8 8 8 8 63 60 86 182 190 78 79 176
271 282 392 425 513 629 703 713 1,122 1,147 1,610 1,954
Total Assets 495 522 649 718 949 1,146 1,479 1,823 2,426 2,664 3,293 3,779

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
95 95 70 234 212 279 326 609 281 375 457 576
-43 -51 -53 -104 -188 -158 -209 -383 -256 -223 -224 -282
-46 -56 -13 -104 -20 -105 -117 -202 -0 -147 -129 -318
Net Cash Flow 7 -11 4 26 4 16 -0 24 25 4 104 -24

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
ROCE % 14% 18% 23% 39% 55% 57% 52% 46% 34% 24% 28% 32%
Debtor Days 86 76 76 59 61 64 78 59 79 82 109 93
Inventory Turnover 1.29 1.63 1.69 1.98 2.35 2.41 2.36 2.09 1.54 1.06 1.49 1.02

Shareholding Pattern

Numbers in percentages

Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021
70.48 70.47 70.47 70.52 70.52 70.51 70.51 70.51 70.51 70.51 70.34 70.34
10.52 10.92 10.13 9.78 9.45 7.68 7.90 8.91 8.23 7.71 7.90 8.37
7.96 8.05 9.26 9.52 9.99 11.81 11.55 10.63 11.03 11.44 11.72 11.86
0.34 0.34 0.34 0.44 0.44 0.65 0.74 0.74 0.74 0.75 0.76 0.76
10.70 10.21 9.80 9.74 9.60 9.35 9.30 9.21 9.49 9.59 9.27 8.67

Documents

Recent announcements


View all

Annual reports

Credit ratings